1. Agarwal A, Khandelwal A, Pal K, Khare N, Jadhav V, Gurjar M, Punatar P, Gokarn A, Bonda A, Nayak N, Kannan S, Gota V, Khattry N, Mitra I (2020) EP1392: a pro-oxidant combination of resveratrol and copper to reduce post-transplant toxicity in patients with multiple myeloma receiving high dose melphalan: results of an exploratory study (RESCU001). Hemasphere 4(S1):668
2. Bartynski WS, Zeigler ZR, Shadduck RK, Lister J (2005) Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoietic malignancies and marrow conditions after allogeneic bone marrow transplantation. Neurocrit Care 3:33–45. https://doi.org/10.1385/NCC:3:1:033
3. Belloumi D, Khemiri H, Drira C, Houissa H, Torjemane L, Ben Abdeljelil N, Soussi MA, Lakhal A, Ladeb S, Khrouf M, Ben Othman T (2020) EP1422: cryotherapy vs supersaturated calcium phosphate rinses in multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized clinical trial. Hemasphere 4(S1):668
4. Bhatt N, Naithani R, Gupta SK (2017) Supersaturated calcium phosphate rinse in prevention and treatment of Mucositis in patients undergoing hematopoietic stem cell transplant. Exp Clin Transplant 15(5):567–570. https://doi.org/10.6002/ect.2016.0180
5. Bhunia N, Abu-Arja R, Bajwa RPS, Auletta JJ, Rangarajan HG (2019) Successful treatment with eculizumab for posterior reversible encephalopathy syndrome due to underlying transplant-associated thrombotic microangiopathy in patients transplanted for sickle cell disease. Pediatr Blood Cancer 66(10):e27912. https://doi.org/10.1002/pbc.27912